Page 15 - Axsm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Axsm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Axsm Today - Breaking & Trending Today

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Recommendation of "Buy" from Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) has been assigned a consensus rating of “Buy” from the twelve ratings firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to […] ....

United States , Allspring Global Investments Holdings , Axsome Therapeutics Inc , Atticus Wealth Management , Zacks Investment Research , Tortoise Investment Management , Nisa Investment Advisors , Jefferies Financial Group , Axsome Therapeutics Company Profile Get Rating , Clearstead Advisors , Axsome Therapeutics , Get Rating , Marketbeat Ratings , Investment Research , Financial Group , Wealth Management , Investment Management , Investment Advisors , Therapeutics Company Profile , Nasdaq Axsm ,

Axsome Therapeutics, Inc. Forecasted to Earn Q2 2022 Earnings of ($1.09) Per Share (NASDAQ:AXSM)

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – SVB Leerink cut their Q2 2022 earnings estimates for shares of Axsome Therapeutics in a report released on Thursday, April 21st. SVB Leerink analyst M. Goodman now expects that the company will earn ($1.09) per share for the quarter, down from their prior estimate of ($1.05). SVB […] ....

United States , Dekabank Deutsche Girozentrale , Steward Partners Investment Advisory , Axsome Therapeutics Inc , Atticus Wealth Management , Zacks Investment Research , Jefferies Financial Group , Wealth Group , Axsome Therapeutics , Get Rating , Financial Group , Investment Research , Wealth Management , Bank Deutsche Girozentrale , Partners Investment Advisory , Nasdaq Axsm , Earnings Estimates , Svb Leerink Llc ,

William Blair Weighs in on Axsome Therapeutics, Inc.'s Q1 2023 Earnings (NASDAQ:AXSM)

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – Analysts at William Blair boosted their Q1 2023 EPS estimates for Axsome Therapeutics in a note issued to investors on Wednesday, April 20th. William Blair analyst M. Minter now anticipates that the company will earn ($0.20) per share for the quarter, up from their prior estimate of […] ....

United States , William Blair , Morgan Stanley , Geode Capital Management , Axsome Therapeutics Inc , Zacks Investment Research , Nuveen Asset Management , Blackrock Inc , Bellevue Group , Jefferies Financial Group , Axsome Therapeutics , Get Rating , Financial Group , Capital Management , Asset Management , Nasdaq Axsm , Earnings Estimates ,

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of "Buy" from Analysts

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) have been given an average recommendation of “Buy” by the twelve brokerages that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and nine have given a buy recommendation […] ....

United States , Thomson Reuter , Steward Partners Investment Advisory , Axsome Therapeutics Inc , Atticus Wealth Management , Zacks Investment Research , Tortoise Investment Management , Nisa Investment Advisors , Jefferies Financial Group , Axsome Therapeutics Company Profile Get Rating , Axsome Therapeutics , Get Rating , Marketbeat Ratings , Investment Research , Wealth Management , Investment Management , Investment Advisors , Partners Investment Advisory , Strs Ohio , Therapeutics Company Profile , Nasdaq Axsm ,